Medical Journals

Material-based Regulation of the Myofibroblast Phenotype.

Authors:
  • Cushing Melinda C
  • Liao Jo-Tsu
  • Jaeggli Michael P
  • Anseth Kristi S

From: Department of Chemical and Biological Engineering, University of Colorado, Boulder, CO 80309-0424, USA.

Biomaterials

  • Publish Date: Aug 2007
  • ISSN: 0142-9612
  • Volume: 28
  • Issue: 23
  • Pages: 3378-87
  • Medium: Print
  • Language: English
  • Citation (JAMA): Cushing Melinda C, Liao Jo-Tsu, Jaeggli Michael P, et al. Material-based Regulation of the Myofibroblast Phenotype.. Biomaterials Aug 2007;28:3378-87

Abstract

Fibroblast growth factor receptor (FGFR) activation by basic fibroblast growth factor (FGF-2) serves to naturally repress the myofibroblast activation of valvular interstitial cells (VICs). Co-receptors for FGF-2, the heparan sulfate proteoglycans (HSPGs), are key participants in the formation of active FGF-2 signaling complexes. Bioactive environments regulating the myofibroblast phenotype were created by utilizing heparin glycosaminoglycan as a competitive inhibitor of HSPGs. First, soluble heparin was delivered to compete with cell-surface HSPG for the binding of FGF-2. Exogenous soluble heparin prevented serum-dependent activation of the classic mitogen-activated protein kinase (MAPK) and induced myofibroblast alpha smooth muscle actin (alphaSMA) expression and collagen production. Next, heparin-functionalized hydrogel cell substrates were polymerized from vinyl-modified precursors and rendered adhesive through incorporation of RGDS peptide. Culture of VICs on heparin-modified gels induced alphaSMA expression and inhibited MAPK activity compared to control gel substrates lacking heparin. Additionally, heparin-functionalized gels continued to induce alphaSMA expression in serum-free culture conditions, suggesting that bioactivity was independent of exogenous soluble mediators. Biomaterial scaffolds targeting cell surface growth factor receptors are a promising new direction for regulating cell functions in tissue-engineering applications.

Mesh Headings (Keywords): Actins, Animals, Aortic Valve, Biocompatible Materials, Cells, Cultured, Collagen, Culture Media, Serum-Free, Dose-Response Relationship, Drug, Enzyme Activation, Fibroblast Growth Factor 2, Fibroblasts, Gene Expression Regulation, Heparan Sulfate Proteoglycans, Heparin, Hydrogel, Mitogen-Activated Protein Kinases, Models, Biological, Muscle, Smooth, Phenotype, Receptors, Fibroblast Growth Factor, Signal Transduction, Substrate Specificity, Swine, Tissue Engineering


Check for Full Text / PubMed Unique Identifier (PMID): 17475322


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.